Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

vincristine/atrophy

Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 244 niðurstöður

Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The distal to proximal degeneration of axons, or "dying back" is a common pattern of neuropathology in many diseases of the PNS and CNS. A long-standing debate has centered on whether this pattern of neurodegeneration is due to an insult to the cell body or to the axon itself, although it is likely

Retinal and optic nerve atrophy induced by intravitreous vincristine in the primate.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Vincristine is known to be toxic to neural tissue, where it is thought to react with microtubules and impair axonal transport. Intravitreous vincristing-induced changes of the retina have been reported to be reversible after 10 micrograms. In the present study, the effects of 0.01 to 100 micrograms

[Study of the effects of isaxonine on retrograde axon degeneration induced by vincristine in man (author's transl)].

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Fifteen patients with Hodgkin's disease were examined before and after each administration of vincristine sulfate (2 intravenous injections of 1.4 mg/m2 of body surface, during the first week of each month for 3 months). Moreover, each patient received daily, according to a double blind protocol,
The effect of topical application of axonal transport blockers to the transected peripheral nerve was assessed by quantitating the strychnine-enhanced transsynaptic degeneration following transection of the inferior alveolar nerve in adult rats. Systemic administration of strychnine (1 mg/kg/day)

Optic atrophy induced by vincristine.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Bilateral optic atrophy developed in a 15-year-old patient receiving concomitant neuraxis radiation therapy and weekly vincristine sulfate for medulloblastoma. Other neurologic manifestations that have been associated with vincristine therapy, including inappropriate secretion of antidiuretic

Pathogenesis of axonal degeneration: parallels between Wallerian degeneration and vincristine neuropathy.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Peripheral neuropathies and Wallerian degeneration share a number of pathological features; the most prominent of which is axonal degeneration. We asked whether common pathophysiologic mechanisms are involved in these 2 disorders by directly comparing in vitro models of axonal degeneration after

CRMP4 mediates MAG-induced inhibition of axonal outgrowth and protection against Vincristine-induced axonal degeneration.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Suppression of inhibition of axonal outgrowth and promotion of axonal protection from progressive axonal degeneration are both therapeutic strategies for the treatment of neuronal diseases characterized by axonal loss. Myelin-associated inhibitors (MAIs) have been shown to suppress axonal outgrowth,
Axon degeneration is a prominent feature of various neurodegenerative diseases, such as Parkinson's and Alzheimer's, and is often characterized by aberrant mitochondrial dynamics. Mitochondrial fission, fusion, and motility have been shown to be particularly important in progressive

The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Neurological diseases are frequently associated with axonal degeneration, which leads to dysfunction though separation of neurons from their targets. The mechanisms of axonal degeneration are largely unknown and in many cases are independent of those occurring within cell bodies in neurodegenerative

Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Chemotherapy-induced peripheral neuropathy is one of the most prevalent dose-limiting toxicities of anticancer therapy. Development of effective therapies to prevent chemotherapy-induced neuropathies could be enabled by a mechanistic understanding of axonal breakdown following exposure to

Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND Severe up to life-threatening neuropathy has been observed in patients with hereditary neuropathies receiving vincristine. METHODS A 52-year-old female painter suffering from high-grade non-Hodgkin's lymphoma (stage IVB) was treated with a total of 4 mg of vincristine during two courses

Neurofibrillary degeneration induced by vincristine therapy.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig

Spheromembranous degeneration of muscle induced by vincristine.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig

Self-hypnosis misinterpreted as CNS deterioration in an adolescent with leukemia and vincristine toxicity.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge